Intellia Therapeutics Inc buy Wells Fargo & Company
Start price
10.01.25
/
50%
€10.22
Target price
10.01.26
€58.40
Performance (%)
-2.43%
Price
18:56
€9.97
Summary
This prediction is currently active. With a performance of -2.43%, the BUY prediction by Wells_Fargo___Compan is trending in the wrong direction. This prediction currently runs until 10.01.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | 10.452% | 10.452% |
| iShares Core DAX® | -0.545% | -0.397% |
| iShares Nasdaq 100 | 0.626% | 1.990% |
| iShares Nikkei 225® | -1.750% | 3.455% |
| iShares S&P 500 | 0.882% | 2.156% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Wells Fargo & Company from $70.00 to $60.00. They now have an "overweight" rating on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.50
28.02.25
28.02.25
€48.09
28.02.26
28.02.26
4.97%
18:56
18:56
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€13.35
18.11.24
18.11.24
€66.07
18.11.25
18.11.25
-25.28%
18:56
18:56